Across the recent three months, 14 analysts have shared their insights on Zimmer Biomet Holdings (NYSE:ZBH), expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. In the assessment of 12-month price targets, analysts unveil insights for Zimmer Biomet Holdings, presenting an average target of $121.79, a high estimate of $145.00, and a low estimate of $107.00. A negative shift in sentiment is evident as analysts have…